Financial statements Improdex
Cash inflows of IMPRODEX
Year
|
2021
|
2022
|
2023
|
---|---|---|---|
Net cash from operating expenses | 15 054 882,33 | 14 672 150,99 | 25 073 027,00 |
Net cash flow from investing activities | -7 135 568,82 | -4 495 535,12 | -4 220 791,40 |
Net cash flow from financial activities | -5 031 687,80 | -7 915 710,90 | -8 021 565,88 |
Total net cash flow | 2 887 625,71 | 2 260 904,97 | 12 830 669,72 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.